Business Context and Reporting Period
This Form 6-K filing by Check-Cap Ltd. (referred to as Mbody AI Ltd. in metadata) covers the period of January 10, 2018. The company is a foreign private issuer based in Israel, reporting pursuant to Rule 13a-16 under the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory and operational updates rather than financial performance data.
Material Changes
On January 10, 2018, the Company announced it received CE Mark approval for its C-Scan system. This regulatory milestone is a material operational development indicating the product meets European health, safety, and environmental protection standards.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, management commentary on future outlook, or a discussion of risks and contingencies. The document serves primarily to incorporate a press release regarding the CE Mark approval by reference.
Investor Verification Checklist
- Verify the specific scope and limitations of the CE Mark approval for the C-Scan system.
- Confirm the timeline for commercial availability of the C-Scan system in European markets following approval.
- Review the attached Exhibit 99.1 (Press Release) for additional details not summarized in the Form 6-K text.
- Check subsequent filings for financial impact or revenue recognition related to this approval.